SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-063213
Filing Date
2023-08-04
Accepted
2023-08-04 08:30:49
Documents
15
Period of Report
2023-08-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182870-8k_adialpharm.htm   iXBRL 8-K 32674
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADIAL PHARMACEUTICAL ea182870ex3-1_adialpharm.htm EX-3.1 17711
3 PRESS RELEASE DATED AUGUST 4, 2023 ea182870ex99-1_adialpharm.htm EX-99.1 13344
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
  Complete submission text file 0001213900-23-063213.txt   258260

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adil-20230803.xsd EX-101.SCH 3060
6 XBRL LABEL FILE adil-20230803_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE adil-20230803_pre.xml EX-101.PRE 22389
9 EXTRACTED XBRL INSTANCE DOCUMENT ea182870-8k_adialpharm_htm.xml XML 3496
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 231142296
SIC: 2834 Pharmaceutical Preparations